RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ifedayo Victor Ogungbe to Drug Discovery

This is a "connection" page, showing publications Ifedayo Victor Ogungbe has written about Drug Discovery.
Connection Strength

1.080
  1. Zhang H, Collins J, Nyamwihura R, Ware S, Kaiser M, Ogungbe IV. Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent. Bioorg Med Chem Lett. 2018 05 15; 28(9):1647-1651.
    View in: PubMed
    Score: 0.603
  2. Metibemu DS, Ogungbe IV. Carotenoids in Drug Discovery and Medicine: Pathways and Molecular Targets Implicated in Human Diseases. Molecules. 2022 Sep 15; 27(18).
    View in: PubMed
    Score: 0.206
  3. Ogungbe IV, Setzer WN. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations. Molecules. 2016 Oct 19; 21(10).
    View in: PubMed
    Score: 0.137
  4. Ogungbe IV, Setzer WN. Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets. Molecules. 2009 Apr 14; 14(4):1513-36.
    View in: PubMed
    Score: 0.081
  5. Coy-Barrera E, Ogungbe IV, Schmidt TJ. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Therapeutics. Molecules. 2023 Apr 25; 28(9).
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support